Join host, Jenna Carmichael, PharmD for a discussion on the role of Nitric Oxide in immune health with guest, Beth Shirley, RPh, CCN. Beth Shirley, RPh CCN is a Registered Pharmacist and Certified Clinical Nutritionist who has developed unique expertise as both a pharmacist and certified clinical nutritionist during a distinguished 40+ year career which she has been a pioneer at the cutting edge of the evolution of what has now come to be known as “Integrative Pharmacy” ...the junction between traditional pharmacy and the clinical use of nutritional supplementation. Since 2009, Beth has worked in close collaboration with some of the world’s leading thought leaders in the field of nitric oxide research. Through this, she has developed an in-depth knowledge on the topic and its potential beneficial applications in multiple aspects of patient care. In addition, she has worked closely with the scientific community and cutting-edge companies working on innovative nutritional ingredients and approaches to their use for a variety of life’s challenges. Beth is currently the Executive Director of Berkeley Life Scientific Advisory Board. Article link: https://bit.ly/3bX2Y7h YouTube Reference: https://www.youtube.com/watch?v=qnyaRVOdhYM To order Berkeley Life go to: https://www.berkeleylife.com/berkeley-life-direct/ and use code JCARMBL Dr. Jenna Carmichael of Wobbly Arrow Wellness is a holistic oncology pharmacist and health coach. She works with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. Go to www.wobblyarrowwellness.com for more information on her services. Learn more about your ad choices. Visit megaphone.fm/adchoices

Significant challenges to widescale clinical implementation of PGx include a lack of physician experience using PGx test data or confidence in interpreting PGx test data and integrating the data into the medication therapy management process. For PGx to be most impactful, prescribers must consider PGx data within the context of other non-genetic patient-specific factors. Pharmacists may help prescribers with PGx test data by creating a summary of medication therapy management recommendations for the patient that streamlines PGx report flags and identifies other pharmacotherapy interventions the pharmacist recognizes while applying non-genetic patient-specific data to the PGx test data. In this episode of the PGx for Pharmacists podcast, Dr. Becky Winslow discusses the research study, "Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation," with two of the research investigators, Dr. Anna Langerveld and Dr. David Bright. Dr. Langerveld and Dr. Bright share how this research adds to the growing evidence that clinical pharmacists can help improve the utility of PGx and prescribing. They also share how their study described a process for reducing PGx laboratory report information to a single page of patient-specific clinical recommendations. Lastly, they share that while clinical decision support tools are becoming more routine for pharmacogenomic management, the pharmacists in this study reduced the number of report-based alerts independent of sophisticated clinical decision support informatics. Anna Langerveld, Ph.D., is the Founder and President of Genemarkers, a contract research organization and CLIA/CAP certified testing laboratory specializing in genomics. Anna received her B.A. in Psychology from SUNY Binghamton and her Ph.D. from the Interdisciplinary Program in Neurosciences at Tulane University. After receiving her Ph.D., Anna served as a Research Assistant Professor at Western Michigan University. She founded Genemarkers in 2008. Under her leadership, Michigan Celebrates Small Business recognized the Company as one of the Top 50 Michigan Companies to watch. Anna is an author of peer-reviewed publications, an NIH grant recipient, and an invited speaker at a wide range of national meetings. Anna currently serves as an adjunct professor and an advisory board member for the Manchester University pharmacogenomics program and holds a community faculty position at the Western Michigan University Homer Stryker M.D. School of Medicine. Anna has been instrumental in developing strategic community partnerships to implement the use of genomics in clinical care, with a particular focus on mental health and underserved populations. Dr. David Bright is a Professor of Pharmacy at Ferris State University, where he has taught therapeutics and medication therapy management. He received his PharmD degree from the University of Toledo, completed a community pharmacy residency with Kroger Pharmacy and the University of Toledo, and served on the faculty at the Ohio Northern University as a community pharmacy residency program director. His research has primarily involved the pragmatic implementation and improvement of non-dispensing pharmacy services, particularly in the outpatient setting. Most recently, that has involved the integration of pharmacogenomics into clinical practice through community pharmacy and ambulatory care practice models. Research discussed in the podcast episode: Bright D, Saadeh C, DeVuyst-Miller S, Sohn M, Choker A, Langerveld A. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation. Pharmgenomics Pers Med. 2020 Dec 10;13:719-724. doi: 10.2147/PGPM.S276687. PMID: 33328756; PMCID: PMC7735940. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735940/ Learn more about your ad choices. Visit megaphone.fm/adchoices

The first in a four-part series detailing medication access for gender-diverse individuals in light of increasingly restrictive legislative action.  As front-line healthcare workers, it’s incumbent upon pharmacists to be paragons of not only equality but equity in healthcare. Gender expansive and nonbinary patients face a massive disparity of outcomes, many of which are improved with gender-affirming therapy. With the expansion of pharmacists’ roles in healthcare, many cases of gender-affirming therapy are often overseen or monitored by pharmacists. The world is changing, and the landscape of healthcare with it. Our audience of pharmacists, pharmacy students, and other healthcare providers need to hear the stories of gender-diverse patients, pharmacists, and advocates who will stop at nothing to bridge the gap to care. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mindy Ferris, RPh, EVP, Operations & Customer Success, and Michael Gerdes, RPh, CCP, Director of Clinical Systems, both at PharmScript, LLC, join our hosts for a candid conversation about long-term care pharmacy growth, transition of care, technology, and how the commitment to caring for people remains key. Learn more about your ad choices. Visit megaphone.fm/adchoices

https://www.michrxconsulting.com/ https://www.linkedin.com/in/michellejsherman/ https://pharmacypodcast.com/podcast/conscious-pharmacist-podcast/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Integrative Pharmacy Solutions to Inflammation and Oxidation w/Beth Shirley Hi dear listeners! I’m excited to announce the guest of the next two episodes will be Beth Shirley, and she will talk about the wonders happening in the world of nitric oxide supplementation. Today we dive into her personal and professional journey and next week we feature a journal club article with my cohost Jenna Carmichael. Beth Shirley, RPh CCN is a Registered Pharmacist and Certified Clinical Nutritionist who has developed unique expertise as both a pharmacist and certified clinical nutritionist during a distinguished 40+ year career. Her specialties include stress-induced hormonal imbalance, intestinal dysfunction, autoimmune and chronic inflammatory issues, detoxification, nutrigenomics and super-normal oxidative stress. She has been a pioneer at the cutting edge of the evolution of what has now come to be known as “Integrative Pharmacy” ...the junction between traditional pharmacy and the clinical use of nutritional supplementation. Since 2009, Beth has worked in close collaboration with some of the world’s leading thought leaders in the field of nitric oxide research. Through this, she has developed an in- depth knowledge on the topic and its potential beneficial applications in multiple aspects of patient care. In addition, she has worked closely with the scientific community and cutting-edge companies working on innovative nutritional ingredients and approaches to their use for a variety of life’s challenges. Learn more about your ad choices. Visit megaphone.fm/adchoices

This is the Cardinal Health 2022 Retail Business Conference summary show.   The Pharmacy Podcast Network was BACK at this years Cardinal RBC in Las Vegas! Listen to our interviews with: Brad Jones, CEO of RMS, Retail Management Solutions Chris Halko, the owner and pharmacist of both Fort Benton and Big Sandy Pharmacies in Montana. Imad Karaze, Pharmacist and Owner, Beaumont Pharmacy Debbie Weitzman, President of Pharmaceutical Distribution at Cardinal Health."  Greco De Valencia, Vice President of Pharmacy at Live Oak Bank. Live Oak Attendees came together at the Mandalay Bay Conference center in Las Vegas from July 13 to 16, marking the 30th anniversary of the Cardinal Health’s RBC event. Learn more about your ad choices. Visit megaphone.fm/adchoices

ConveyMED, a division of Convey Pro, Inc. today announced a new partnership with the Pharmacy Podcast Network. With ConveyMED, PPN content creators can now deliver a superior educational experience to pharmacists on a proprietary podcast platform designed to optimize the medical education experience. “We are thrilled to partner with the Pharmacy Podcast Network to provide mobile medical education to the integrated treatment team,” says Mike Donoghue, CEO at ConveyMED. “The PPN is a pioneer in podcast medical education. Our vision is to elevate podcasting as a medium for medical education for all healthcare providers and we welcome all pharmacists to the industry-leading ConveyMED App.” “The Pharmacy Podcast Network has been searching for a platform like ConveyMED for years,” stated Todd S. Eury, founder and CEO of PPN. “Our vision is to provide peer-reviewed, accredited content to our listeners to help them achieve their educational goals and improve patient care. The ConveyMED App exceeds our expectations, and their Founders are committed to a bold new educational experience for healthcare providers.” In this partnership, Content Creators will have access to a podcast platform that will allow them to broaden their educational offerings and monetize their content. Pharmacists will benefit by accessing peer-reviewed educational content in a popular mobile format and earn continuing education credit on-the-go.  ConveyMED invites all 130,000+ monthly PPN listeners to its platform. The first premium audio content to be released on the ConveyMED platform will be the NAPLEX Podcast developed by Dr. Chloe Givens PharmD. The NAPLEX Podcast is a supplemental learning collection of 70+ podcast episodes to help pharmacy students prepare for the North American Pharmacist Licensure Examination. INTERESTED IN WORKING WITH OTHER PODCAST CONTENT CREATORS?  Contact us: https://conveymed.io/pharmacy-podcast-network/  About ConveyMED: ConveyMED is Medical Education for the Mobile Generation. We exist to bring educators and professional learners together on a podcast platform built for continuing education and provide them with the most robust podcast learning experience possible. For more information, visit the ConveyMED website, Twitter, or LinkedIn About the Pharmacy Podcast Network: The first network of podcasters dedicated to the pharmacy industry, PPN boasts 40+ content developers, 125,000 listeners, and is ranked in the top 2% of all podcasts globally. The PPN partners with multiple leading organizations such as the American Pharmacist Association, the California Pharmacist Association, and Pennsylvania Pharmacist Association, and the National Association of Specialty Pharmacies. PPN was awarded the 2022 Health & IT Marketing Community (HITMC) Podcast of the Year. Learn more about your ad choices. Visit megaphone.fm/adchoices

We talk with Greg Johnsen, CEO at Lifelink Systems, Inc. #TogetheRx we are transforming patient engagement across the healthcare industry by giving hospital systems and life sciences companies advanced conversational technology to interact with patients where they spend their time — messaging on mobile devices. Our technology turns the smartphone into the next-generation healthcare worker, capable of handling complex workflows at unlimited scale. Information technology has come a long way, but successful user engagement has proven to be a surprisingly daunting last-mile challenge. Healthcare is complicated and the digital tools offered to patients reflect that, which results in low adoption and satisfaction. Delivering digital patient experiences remains a strategic priority, but the healthcare industry needs to reimagine patient-facing technology. The challenge remains: How do we make the complex exceedingly simple, exceedingly intuitive? It turns out that the simplest, most intuitive human interface is a conversation. It’s natural, requires no training, is infinitely flexible, self-directed, and responsive. With smartphone adoption rates approaching 90%, the opportunity to engage in conversation-based information exchanges is in the palms of everyone’s hands. Today, any human with a mobile phone can converse with complex IT systems with ease, and immediately, by relying on smart, context-aware digital assistants. The technology for enabling conversational AI will transform consumer engagement strategies across every industry sector, but it will have an especially profound impact on process-centric customer care industries. Like Healthcare. Conversational AI not only closes a service gap, it improves the quality of the service itself while also providing the engagement horsepower to scale up service operations profitably. Digital assistants carry the encoded protocols, orders, and best practices to the patient in the form of smart, engaging conversations. Importantly, conversational AI technology doesn’t replace human expertise and services, it augments care teams by taking on all of the redundant, high-volume processes. Companies that are taking advantage of this powerful new technology are transforming the patient experience, and dramatically improving customer service across the board. Learn more about your ad choices. Visit megaphone.fm/adchoices

Let’s face it, when it comes to pain management, one of the most painful efforts of the last few years has involved, in one way, shape, form, or fashion: Morphine Milligram Equivalents (MMEs). As we discussed with the PharmD author of the 2022 CDC Opioid Guideline Update , there are no MME factor changes on the horizon, so just when will we have our minds wrapped around the concept?!?   Join the Mark “Pain Guy” Garofoli on the Pain Pod for a dynamic discussion on wrestling (yes, you read that right!), pain management, our healthcare system, and the “street” version of MMEs. Wait, there’s a street version of MMEs? Yes, yes there is, so tune in now to the Pain Pod as you’ll only utilize the edge of your seat even though ya paid for the whole seat!   Come one, come all, to the Pain Pod!!!   Episode Notes   Pre-2016 MME Charts Review 2016 CDC Chronic Pain Opioid Guideline MME Chart ·      CDC Chronic Pain Opioid Guidelines: MMWR March 2016. Updated 2017. o   Tramadol: 0.1 o   Codeine: 0.15 o   Tapentadol: 0.4 o   Morphine: 1 o   Hydrocodone: 1 o   Oxycodone: 1.5 o   Oxymorphone: 3 o   Hydromorphone: 4 o   Methadone (Up to: 20mg, 40mg, 60mg, >60mg): 4, 8, 10, 12 o   Transdermal Fentanyl: 7.2 (Divided by the # of Days Applied) o   Transdermal Buprenorphine: 12.6 (Divided by the # of Days Applied) o   Buprenorphine (SL or Buccal): 0.03 (for mcg calculations) or 30 (for mg calculations) · Nielson S. et. al. A synthesis of oral morphine equivalents (OME) for opioid utilization studies. Pharmacoepidemiology and drug safety 2016; 25: 733–737     2015 Cat and Dog MME Article · https://burrardvet.com/2015/04/08/pain-control-in-dogs-cats   2016 CDC Chronic Pain Opioid Guideline MME Chart · CDC Chronic Pain Opioid Guidelines: MMWR March 2016. Updated 2017.   2022 CDC Opioid Guideline Revision Resources · https://www.federalregister.gov/documents/2022/02/10/2022-02802/proposed-2022-cdc-clinical-practice-guideline-for-prescribing-opioids   2010 to 2014 MME Relative Risk of Overdose/Death · https://i1.wp.com/face-facts.org/wp-content/uploads/2017/04/Opioid-dose-vs-overdose-risk.jpg   Missouri Marijuana Equivalents (MMEs) · https://north.life/demystifying-missouri-medical-marijuana-equivalency-units-mmes/     Audio Add-in’s Let’s Get Ready to Rumble (Michael Buffer) · https://www.youtube.com/watch?v=jgopHWACUXs   Cash sound · https://www.youtube.com/watch?v=ZeET7Z1ZGlw   Ron Burgundy “That Escalated Quickly” · https://www.youtube.com/watch?v=FONN-0uoTHI Learn more about your ad choices. Visit megaphone.fm/adchoices

Your ability to produce Nitric Oxide (N-O) declines rapidly as you age. Berkeley Life Professional’s proprietary dietary nitrate blend provides the plant-based bio-equivalents of a leafy green diet in each two capsule dose helping you maintain Nitric Oxide levels as you age. This interview with Berkeley Life CEO John Halbert is a terrific testimonial to the importance of the supplement and to the revenue opportunity for community pharmacies. RxSafe, RMS, and Berkeley Life will be sponsoring the 2022 Pharmacy Profit Summit in Dallas Texas hosted by DiversifyRx. Learn more: https://www.berkeleylife.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Greco DeValencia of Live Oak Bank and Owen BonDurant and Rich Danhof of Independent Rx discuss the recent rate hikes, how it affects current pharmacy owners and owners to be and what to be concerned about beyond just the headlines of rising rates. Learn more about your ad choices. Visit megaphone.fm/adchoices

Accreditation and support statement: · PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. · This activity is supported by educational grant from GlaxoSmithKline. Objectives • Review the guideline-recommended role of immune-based therapies in the management of endometrial cancer. • Discuss access to care, cost of care and cost-effectiveness of Immune checkpoint inhibitors in the treatment of endometrial cancer.   Learn more about your ad choices. Visit megaphone.fm/adchoices

 Educational Objectives ·      Discuss currently available options for pre-exposure prophylaxis (PrEP) in the prevention of HIV. ·      Describe the role of pharmacists in improving PrEP uptake in the United States.      Faculty: Drew W. Cates, PharmD, AAHIVP, Educational Manager SynerGrx Chamblee, Georgia  Faculty, has the following financial relationships with commercial interests to disclose: Speaker's Bureau: Gilead   Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.07 CEU) under the ACPE universal activity number 0290-0000-22-338-H02-P. The activity is available for CE credit through July 29, 2023. This activity is supported by an educational grant from ViiV. Learn more about your ad choices. Visit megaphone.fm/adchoices

Educational Objectives • Review the targetable mutations RET, MET, and KRAS, including associated agents for the treatment of metastatic non-small cell lung cancer (NSCLC) • Discuss the ways a pharmacist may improve adherence, toxicity management, and outcomes for patients with metastatic NSCLC expressing RET, MET, and KRAS mutations   Josiah D. Land, PharmD, BCOP Clinical Pharmacy Specialist – Thoracic Medical Oncology Department of Pharmacy Memorial Sloan Kettering Cancer Center New York, New York   Josiah D. Land, PharmD, BCOP, has the following financial relationship with a commercial interest to disclose: Consultant (advisory board): Bristol Myers Squibb   Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number0290-0000-22-388-H01-P. The activity is available for CE credit through July 29, 2023.   This activity is supported by educational funding provided by Amgen. Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode interviews Dr Alyson McGregor, MD Professor of Emergency Medicine and Associate Dean of Clinical Faculty Affairs and Development at University of South Carolina School of Medicine Greenville.  Dr McGregor is a sex and gender expert, educator and advocate. Dr McGregor discusses her book, Sex Matters: How Male-Centric Medicine Endangers Women's Health and What We Can Do About It.  https://www.alysonmcgregormd.com/ @amcgregormd Learn more about your ad choices. Visit megaphone.fm/adchoices

Educational Objectives ·      Review the efficacy and safety of emerging frontline immune checkpoint inhibitor (ICI) used as monotherapy and in combination regimens ·      Indicate the impact of ICIs and programmed death-ligand 1 testing on cost-effectiveness and patient reported outcomes related with frontline use of ICIs in advanced NSCLC   Faculty: Paul Forsberg, PharmD, MHA, BCOP Director of Pharmacy Minnesota Oncology St. Paul, Minnesota   Latha Radhakrishnan, PharmD, BCOP Clinical Oncology Pharmacist The University of Illinois Hospital and Health Sciences System Clinical Assistant Professor University of Illinois at Chicago College of Pharmacy Chicago, Illinois   Paul Forsberg, PharmD, MHA, BCOP, has the following relevant financial relationships with commercial interests to disclose: Consultant: Epizyme Speakers Bureau: AstraZeneca   Latha Radhakrishnan, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Consultant: Taiho, Novartis, Exelixis Speakers Bureau: BMS, AstraZeneca, Taiho, Exelixis   Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta. Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-22-363-H01-P. The activity is available for CE credit through July 29, 2023.   This activity is supported by independent medical education grants from Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Inc., and Sanofi Genzyme.  https://www.pharmacytimes.org/courses/continuing-the-conversation-optimizing-frontline-immunotherapy-outcomes-in-nsclc-and-managed-care-considerations Learn more about your ad choices. Visit megaphone.fm/adchoices

4 Can't Miss Trends about Digital Engagement! Coming up on Friday's livestream of the DarshanTalks Podcast with host Darshan Kulkarni and guest Ritesh Patel, originally streamed on July 15th, 2022.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to Dexcom G6 User Guide. For product-related questions, please refer to instructions for use. For complete safety information, go to dexcom.com/safety-information Smart devices are sold separately. For a list of compatible smart device visit Dexcom.com/compatibility  Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.  Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products. The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G6 System User Guide  Safety Information https://www.dexcom.com/safety-information  Dexcom Follow app: The Dexcom G6 App allows you to share your glucose data with up to 10 people. By downloading the Dexcom Follow App, followers can view your glucose data directly from their smart device† whether they live down the street or across the country*. Connectivity – basics (https://provider.dexcom.com/dexcom-cgm/collaborators) About Dexcom https://www.dexcom.com/about-Dexcom Beacon Health System Resources Dexcom Patient Training and Resources Dexcom Prescribing Information Brief Safety Statement Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. The web-based Dexcom CLARITY software is intended for use by both home users and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them. Caution: Federal (US) law restricts this device to sale by or on the order of a licensed healthcare professional. Dexcom, Dexcom Follow, Dexcom CLARITY, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries. References: 1.    William H. Polonsky, Emily C. Soriano, and Addie L. Fortmann. Diabetes Technology & Therapeutics. Ahead of print http://doi.org/10.1089/dia.2021.0526 2.    Shah VN, et al. Diabetes Technology & Therapeutics. 2018;20(S1):A-27 DOI: 10.1089/dia.2018.0143 3.    Kaushik S, et al. Diabetes. 2020 Jun;69(Supplement 1) https://doi.org/10.2337/db20-79-LB  Learn more about your ad choices. Visit megaphone.fm/adchoices

Solid PR practices call for changing the conversation to one's advantage, but PCMA's recent OpEds based on a paid-for white paper are more than suspect.  Listen in as lobbyist & managing partner of Public Policy Partners Meghaen Della'Artino, and General Counsel for American Pharmacies Miguel Rodriguez, speak with PUTTcast host Monique Whitney about strategy, the current political arena, and how the power of grassroots and a constituent's voice can overcome the most well-funded PBM politics. Learn more about your ad choices. Visit megaphone.fm/adchoices

Babson Diagnostics and Pharmacy Podcast Network Announce Partnership That Will Take Listeners Inside Largest Retail Pharmacy Trade Show Babson to host popular podcast from its booth at the Total Store Expo July 26, 2022 Austin, Texas– Babson Diagnostics, a science-first, health care technology company, today announced a media partnership with the Pharmacy Podcast Network in connection with the 2022 National Association of Chain Drug Stores’ Total Store Expo, the largest gathering of retailers and suppliers in the health and wellness industry.  As part of the partnership, the Pharmacy Podcast Network, the most popular and downloaded podcast about the pharmacy industry, will be integrated into Babson Diagnostics’ booth at the Total Store Expo. Todd Eury, founder and chief executive officer of the media company, will host podcasts from the booth featuring industry leaders attending the trade show. In addition, Babson will sponsor two podcasts that will be broadcast prior to the expo, which takes place Aug. 27 through Aug. 29 in Boston. The first of those shows, “Diagnostic Testing in Community Pharmacies” went live today. “Babson is excited to be collaborating with one of the leading media outlets aimed at community pharmacists, who are the face of neighborhood healthcare, said David Stein, CEO of Babson Diagnostics. “Babson is working with pharmacies to offer medically accurate blood testing that is easier, more convenient and less invasive than traditional methods.” Launched in 2009, the Pharmacy Podcast Network reaches more than 80,000 listeners per month with audio content focused on the critical role pharmacists play in the healthcare industry. “I look forward to bringing exciting new content to my audience through this partnership with Babson Diagnostics,” Eury said. “The Total Store Expo is a one-of-a-kind opportunity to bring insights to pharmacists about new and innovative products and services in health and wellness, such as Babson’s blood-testing ecosystem.” Please visit the Babson at booth #359 at the Total Store Expo to see Eury’s interviews, view the blood testing ecosystem, experience the collection technology, meet the team and more. Sign up at www.babsondx.com/nacds About Babson Diagnostics Babson Diagnostics is a science-first healthcare technology company bringing convenient, medically accurate diagnostic blood testing to the local pharmacy. We are the first and only company to do broad blood panels from a capillary microsample, collected from a finger, at a retail setting. Our core technology was incubated at Siemens Healthineers ​in 2015, and we became Babson Diagnostics in 2017. We have exclusive partnerships with Siemens Healthineers and BD (Becton, Dickinson and Company), two global leaders in healthcare innovation and medical technology. Together we are reimagining the entire blood testing process, helping people get the care they need, when they need it. Babson, based in Austin, Texas, is named in honor of Art Babson, whose legacy of scientific innovation and excellence is the foundation on which the company is built. For more information visit www.babsondx.com and find us on Facebook (@babsondx), Twitter (@babsondx) and LinkedIn (@babsondx). About Pharmacy Podcast Network Pharmacy Podcast Nation is the flagship show hosting all of the Pharmacy Podcast Network 1400+ episodes. With more than 30 different podcast programs and some 40 different co-hosts helping to develop audio content about the pharmacy sector, its reach includes communities, hospitals, senior-care residences, military and public health settings that meet the information needs of 300,000 pharmacists with more than 100,000 monthly listeners. PPN also delivers a unique publication called Rx Influencer to all healthcare professionals with a specific focus on pharmacy. For more information visit: https://pharmacypodcast.com/ Contacts: Babson Joe Foster Babson Diagnostics [email protected] 323-572-5361 Learn more about your ad choices. Visit megaphone.fm/adchoices

COVID-19 has reminded us of the importance of nurses in our lives and why we must invest in them. Healthcare is one of the hardest-hit areas of the Great Resignation, with stress and burnout leading to nurses leaving the profession in high numbers. Learn from prominent healthcare experts how to limit the impact of nursing shortages by leveraging intelligent infrastructure, automation, and data intelligence. Learn more about your ad choices. Visit megaphone.fm/adchoices

Introduction of faculty and disclosures:  Dr. Kathryn Maples is a clinical pharmacy specialist in multiple myeloma at the Winship Cancer Institute with Emory Healthcare in Atlanta, Georgia. Dr. Maples has the following relevant financial relationships with commercial interests to disclose: consultant for GlaxoSmithKline, Janssen, Karyopharm, and Sanofi. Accreditation and support statement:  PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC  https://www.pharmacytimes.org/courses/multiple-myeloma-pharmacists-as-therapy-experts Learn more about your ad choices. Visit megaphone.fm/adchoices

How does it feel to be torn between two vastly different worlds: the one you were born to, and the one you fled to and eventually thrived in? What does it mean to become an American?  Trading Grenades for Candy is a memoir of a Kurdish woman who fled war and turmoil in Iraqi Kurdistan as a young child and transformed herself into a quintessential American success story. Hers is a richly expressed and deeply personal journey from barely surviving in a mud house amidst landmines, to evolving into an independent, world-traveling pharmacist. By understanding her personal story of hardship and perseverance, readers will come to understand not only her personal triumph, but the wider story of the Kurdish people. This memoir will change the way one looks at what it means not only to be an American, but a fellow human being in our diverse world.  This special edition of 'Transforming a Nation' is with Dr. Helen Sairany, PharmD., author of Trading Grenades for Candy: A Kurdish Refugee's American Journey Learn more about your ad choices. Visit megaphone.fm/adchoices

Have you ever wondered what the life of a Second Year Medical School Student is like? Check out today's show to find out! Topics covered include basic medical school application recommendations, an in-depth look at what Osteopathic Medical school is like, the importance of conducting research, an introduction of the national medical boards (USMLE STEP 1), and finishing up with expectations for clinical rotations! Links: 1. Difference Between DO and MD Degrees: https://www.usnews.com/education/best-graduate-schools/top-medical-schools/articles/2019-11-07/the-difference-between-do-and-md-degrees 2. Medical School Application Platform; AMCAS - https://students-residents.aamc.org/ 3. American Association of Colleges of Osteopathic Medicine (AACOM): - https://www.aacom.org/ 4. The Physician Pharmacist: www.PhysicianPharmacist.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Optimal medication use is multi-faceted in its dependencies on regimens, prescribing physicians, clinical oversight by pharmacists and behavior of individuals; and suboptimal medication use is broad and far-reaching in clinical, quality of life and economic consequences.  Suboptimal use of medications is not only prevalent and consequential, but also represents a significant portion of the aggregate risk for poor events in a population that can be reduced through intervention and proper application of patient supports. This is an environmental scan of the existing aids and devices along with synchronization strategies intended to support optimal medication use.  To date, multiple but disparate approaches to influence and achieve optimal medication use have been deployed. They lack unifying modalities and interventions that can be applied broadly. We have used this analysis to bring forth a roadmap for a best in class solution that connects healthcare to the home, with access that extends into the daily lives of patients, creating a passive omnipresence and connectedness with healthcare team members and family caregivers. https://spencerhealthsolutions.com/wp-content/uploads/2021/02/Fulfilling-the-Promise-of-Medications.pdf?utm_campaign=Thought%20Leadership%20-%20External&utm_content=203395111&utm_medium=social&utm_source=twitter&hss_channel=tw-1097123424395292673  Learn more about your ad choices. Visit megaphone.fm/adchoices

Host Jason Callori talks with Chad Sanders, Director of Pharmacy Acquisition at Cardinal Health, about the current landscape of buying and selling pharmacies, and what you need to know to be successful.  Learn more about your ad choices. Visit megaphone.fm/adchoices

We believe that local independent community pharmacy has a much wider role to play in future home-care. Historically, pharmacists have not been included on home care teams, despite the fact that home care patients require more pharmacy care services and frequently experience medication errors. There’s an opportunity for Community Pharmacies to deliver more in-home care services. LTC pharmacies are compensated for services which many community pharmacies provide to their home-bound patient base. The optimal service delivery model of community pharmacies and distribution of additional clinical care for home care is a prime opportunity.  Special thanks to our episode sponsor RxSafe, leaders in Medication Adherence packaging & partners of Independent Community Pharmacy.  Guests:  Ronna Hauser, PharmD SVP Policy & Pharmacy Affairs at NCPA Susan Rhodus, BS Pharm  Senior Vice President, Contracts and Advocacy at GeriMed Joe Williams, PharmD Owner at Brisson Drugs References:  https://ncpa.org/medical-home-mah  Learn more about your ad choices. Visit megaphone.fm/adchoices

Blueberry Pharmacy is creating an entire new way to think of retail pharmacy and what Kyle McCormick, PharmD., is doing is beyond remarkable. He has gone all cash. Just think about this, no PBM’s, nor third party audits or pre-authorization hassles.  The pharmacy stocks only generics, does a super job of providing one-on-one care and his patients love it, and tell their friends. In this podcast Kyle tells Bruce Kneeland, and co-host Robyn Amberg, how he got started along with the rationale for how and why it works. I think you’ll love listening to the story of how a true pharmacy pioneer has taken off on a new path.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Apps are now an integral part of our daily micro-moments, with people spending an average of 30 hours per month in them, according to Nielsen Although these seem like big tech corporations, they enabled smaller businesses to a degree. For instance, local restaurants that would’ve normally closed during the pandemic due to dining restrictions became dependent on delivery clients. People have mixed feelings about these tech apps - on the one hand, they want to support local community businesses by going to them directly, but on the other hand, they are dependent on these apps to facilitate their life.  Mobile technology has been crucial to every industry, as mobile phones are the first and last tangible step in peoples’ routines. Families are more likely to get a phone before a computer for the household - so mobile optimization has to be up to the standard usability of a desktop. Our guests:  Dr. Anthony Do PharmD is a Pharmacist, with over a decade in experience working in practice at Kaiser, software engineer and is now CEO and founder of Rx Delivered Now. He earned his doctoral from Western University college of Pharmacy where he was also president of the NCPA chapter. Dr. Ken Thai PharmD co-founded 986 Pharmacy in July 2014. He is the CEO and serves on its Board of Directors. Dr. Thai earned his Doctoral from USC School of Pharmacy and went on to complete his residency in community pharmacy practice Learn more about your ad choices. Visit megaphone.fm/adchoices

On today's episode, we welcome Ryan Ray, PharmD, a clinical pharmacist and Certified Diabetes Care and Education Specialist for Wellpower. As a staff pharmacist, Dr. Ray's responsibility is to collaborate with other mental health staff providers to help his patients manage their diabetes and help understand the long term complications of poor diabetes control. In addition to his staff pharmacy role, he is also integrated into diabetes care and education into WellPower's integrated Primary Care Unit. Dr. Ray is focused on addressing health inequities he has identified over his years of experience with the SMI population. This work includes creating a new curriculum to teach DSMES to the SMI population and using and advocating for advanced technology to be incorporated into his practice and diabetes practice as a whole. Join us as we discuss the successes and challenges with the SMI population and how to overcome some barriers! Learn more about your ad choices. Visit megaphone.fm/adchoices

Alan Rosenbloom, founder of the Senior Care Pharmacy Coalition (SCPC), joins  Frances Nahas, Chief Strategy Officer at RedSail Technologies, and Jim McDonald,  Vice President of Sales, for a candid discussion on the shifting landscape of long-term  care and how pharmacies can stay abreast of the policies that will create a myriad of  opportunities and challenges in how care is accessed and provided. Learn more about your ad choices. Visit megaphone.fm/adchoices

During his eight-year tenure at Albany College of Pharmacy and Health Sciences, Dr. Greg Dewey accomplished many great things. In this episode of Occupation Station Dr. Dewey reflects on The Collaboratory, the Stack Family Center for Biopharmaceutical Education and Training (CBET), and the creation of two student-run pharmacies.     The Collaboratory, a “laboratory for collaboration,” offers services which are delivered to residents in Albany by ACPHS’s Public Health Pharmacy Team and Trinity Alliance’s Wellness Advocates Linking Communities (WALC) team. Programs at The Collaboratory address social justice and social determinants of health with the shared goal of improving population health. CBET is an evolutionary leap in health sciences education and biomanufacturing workforce training. Dr. Dewey is perhaps most proud of the creation of two student-run pharmacies both situated in what would be deemed “pharmacy deserts.” The pharmacies, which are located in Albany and Schenectady, N.Y., are prime examples of social entrepreneurship and are designed to have a lasting impact on the communities they serve, while also helping to develop skills that students will benefit from. Dr. Dewey explains that social entrepreneurship involves being self-sustaining while doing public good.      Because of his relationships with faculty, staff, and students, coupled with the development of these crucial initiatives, Dr. Dewey has found his work at ACPHS to be greatly gratifying. And because of his enormous contributions at ACPHS he will be greatly missed! Learn more about your ad choices. Visit megaphone.fm/adchoices

As an innovative method to improve the affordability of costly biological therapies, there's new medication products being developed with the needed approval of the Food and Drug Administration (FDA) for biological products that are “highly similar” (biosimilar) to or interchangeable with traditional drug developed products. Biosimilars are not completely identical to the innovator product because of the large molecular size, complexity and proprietary nature of the manufacturing process, and inherent variability of all biopharmaceuticals. Dr. Sonia Oskouei, PharmD, BCMAS, DPLA is Vice President of Biosimilars at Cardinal Health. Sonia shares her experiences in the biosimilars sector of drug development and shares how we're entering these new therapeutic areas, with ophthalmology being the latest focus. Sonia explains how we need more information to help build clinical confidence in these agents. So, any type of data or evidence in understanding of the FDA approval pathway and the associated scientific rigor from the FDA is key to helping build clinical confidence. "Pharmacists are becoming more and more involved in the care team, particularly in oncology and in the health system setting. So, pharmacists often are partnering or leading with physicians to champion the education process associated with biosimilars, and that's multistakeholder education, both physicians, other pure pharmacists, and supporting patients and their journey. Pharmacists are also strong contributors to biosimilar adoption and management, particularly in the health system setting as a lead often for formulary decisions, P&T committee involvement, where they're looking not only at the clinical considerations of biosimilars but incorporating the economic and even operational considerations associated with these products, so understanding the complete picture and how best to optimize and leverage biosimilars within their institutions." Learn more about your ad choices. Visit megaphone.fm/adchoices

Daisy Bravo is an online pregnancy & postpartum fitness coach and the founder of Strong Moms Fitness. Her passion for health and fitness has led her to a 20-year career supporting moms to reach their health and fitness goals.  Early on in her personal training career, she noticed that many trainers in the gym did not know what to do with pregnant women and new mothers. She identified two types of trainers; the ones that we’re afraid to work with moms and the ones that either ignored or were unaware that these women needed special consideration.  Sick of seeing this population ignored in standard fitness programs, and also wanting for herself to have a fit pregnancy. Daisy spent years learning how to help herself and other women have an empowered pregnancy. It wasn’t long into her studies that Daisy realized it was her destiny to work with pregnant and postpartum women and continue to raise awareness that women can be a badass in the gym…even if they are pregnant or a new mom. Daisy’s mission is to support moms who feel pressure from society to quickly lose weight after baby.  In their effort to look good on the outside it is so common to see moms resume pre-baby activities only to find themselves injured and left to accept that things like diastasis, prolapse, and leakage are normal. Through Daisy’s coaching programs she supports, empowers, and educates women on how to workout safely during pregnancy and then recover and return to exercise after giving birth, without risking injury and avoiding those crash diets. Social Media -  WEBSITE | INSTAGRAM | FACEBOOK GROUP | PINTEREST | YOUTUBE Podcast - https://www.strongmomsfitnesspodcast.com/ Book - http://flatabsafterbaby.com/ use coupon code PHARMACIST for 20% off Media Kit with Bio & Images -  Daisy Bravo Media Kit - Strong Moms Fitness Learn more about your ad choices. Visit megaphone.fm/adchoices

Have you ever considered a career in medicine after pharmacy? Join us today to explore what the first year of medical school is like and how it compares to pharmacy! In today’s show, we will cover topics related to application logistics, basic MCAT principles, application timing, applying to pharmacy residencies, tackling pharmacy boards, adjusting to the medical school life, and reflections on a career in medicine! Links: 1. Medical School Application Platform; AMCAS - https://students-residents.aamc.org/ 2. American Association of Colleges of Osteopathic Medicine (AACOM): - https://www.aacom.org/ 3. Medical School Acceptance Rates By Major in 2022 (BeMo) - https://bemoacademicconsulting.com/blog/medical-school-acceptance-rates-by-major Learn more about your ad choices. Visit megaphone.fm/adchoices

Congressman Buddy Carter and General Counsel of NCPA Matthew Seiler on PBM Reform. On this episode of the 'PBM Reform Podcast' we discuss the Pharmacy Benefit Manager (PBM) Transparency Act of 2022 (the Act) was recently proposed in the U.S. Senate and intends to incentivize “fair and transparent” PBM practices, prohibit spread pricing and claw backs of payments to pharmacies, and empower the Federal Trade Commission (FTC) and state attorneys general in enforcement actions to stop “unfair and deceptive” PBM business practices. The Act was introduced by Senators Maria Cantwell Chuck Grassley on May 24, 2022, and was approved by the Commerce Committee with bipartisan support (19-9) on June 22, 2022. This summary provides a high-level overview of the Act’s key measures. Prohibition on Unfair or Deceptive Prescription Drug Pricing Practices The Act would make it illegal for PBMs to: Engage in “spread pricing,” which is described as charging a health plan or payer a different amount for a prescription drug’s ingredient cost or dispensing fee than the amount the PBM reimburses a pharmacy for the prescription drug’s ingredient cost or dispensing fee where the PBM retains the amount of any such difference; Arbitrarily, unfairly, or deceptively reduce or rescind (a.k.a. “claw back”) any portion of the reimbursement payment to a pharmacist or pharmacy for a prescription drug’s ingredient cost of dispensing fee; or Arbitrarily, unfairly, or deceptively increase or lower fees and reimbursements to a pharmacy to offset reimbursement changes under any federally funded health plan. The Act would incentivize transparency by stating that a PBM shall not be in violation of the Act if the PBM passes through 100% of price concessions to a health plan or payer and provides complete disclosure of: The cost, price, and reimbursement of prescription drugs to each health plan, payer, and pharmacy; All fees, markups, and discounts the PBM charges or imposes on each health plan, payer, and pharmacy; and The aggregate remuneration PBM receives from drug manufacturers, including nay rebate, discount, administration fee, and any other payment or credit obtained or retained by PBM. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Jennifer N. Lind, PharmD, MPH, MBA Jennifer N. Lind, PharmD, MPH, MBA, is a Pharmacist and Epidemiologist in CDC’s Medication Safety Program and a Commander in the United States Public Health Service Commissioned Corps. CDR Lind received her Doctor of Pharmacy degree from Florida A&M University in 2007, Master of Public Health from Georgia State University in 2012, and Master of Business Administration from Emory University in May 2022. After receiving her MPH, she completed a two-year fellowship as an Epidemic Intelligence Service (EIS) officer in CDC’s National Center for Chronic Disease Prevention and Health Promotion, conducting research and surveillance related to infant and young child feeding practices.  Following EIS, she worked in CDC’s Birth Defects Branch and eventually became the Lead Scientist for CDC’s Treating for Two initiative, focused on safer medication use in pregnancy. CDR Lind’s current work in CDC’s Medication Safety Program focuses on reducing harms from the use of medications and she serves as Lead Pharmacist for the PROTECT initiative, an innovative public-private partnership that uses a collaborative, data-driven approach to reduce harms from unintentional medication overdoses in children. CDR Lind has also been a leader in multiple emergency responses, including COVID-19.   During her 15 years of experience, CDR Lind has authored/co-authored 35 publications, presented at national and international conferences, and has been interviewed/featured by numerous media outlets, including the national radio show “Top of Mind with Julie Rose,” USA Today, Consumer Reports, CNN, The Doctors Channel, and HealthDay News. For more information regarding CDC’s Medication Safety Program, the PRevention of Overdoses and Treatment Errors in Children Taskforce (PROTECT) Initiative, and Up & Away, please visit: www.cdc.gov/medicationsafety   For the most up-to-date information regarding COVID-19 vaccination, please visit: www.cdc.gov/vaccines/covid-19 To learn more about the United States Public Health Service Commissioned Corps, please visit: www.usphs.gov To learn more about the Epidemic Intelligence Service (EIS) program, please visit: www.cdc.gov/eis   Learn more about your ad choices. Visit megaphone.fm/adchoices

Join host Jenna Carmichael, PharmD for a discussion on Antimycobacterial activity of acetone extract and isolated metabolites from folklore medicinal lichen Usnea laevis Nyl. against drug-sensitive and multidrug-resistant tuberculosis strains with guest Susan Egbert, PharmD.  Susan (she/her) completed her PharmD at the University of Louisiana at Monroe (ULM). During school, she realized that there's still not a lot done on natural products despite a fair number of drugs having natural origins. Currently, Susan is a third year PhD candidate in chemistry at the University of Manitoba (U of M). Her research is focusing on lichens, biosynthesis of their secondary metabolites, and their pharmacological activity. Article link: https://pubmed.ncbi.nlm.nih.gov/34536516/  How to get in touch with Susan: Email: [email protected]  Twitter: @lichenlady94 Instagram: @lichenlady94 Dr. Jenna Carmichael of Wobbly Arrow Wellness is a holistic oncology pharmacist and health coach. She works with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. Go to www.wobblyarrowwellness.com for more information on her services. Learn more about your ad choices. Visit megaphone.fm/adchoices

Podcast Participants: Mike Baldzicki (AscellaHealth), Randy Falkenrath (President, Onco360), Justin Manning, PharmD (Group Vice President, Business Development, Vivid Clear Rx) Summary: The specialty pharmacy patient journey is a process, and it starts at the point of care with patient and prescriber, and it goes all the way through the treatment of therapy. Specialty Pharmacy is defined as the service created to manage the handling and service requirements of specialty pharmaceuticals, including dispensing, distribution, reimbursement, case-management and other services specific to patients with rare and/or chronic diseases. There are a lot of extra steps in dispensing a specialty medication, so there's a lot of work to be done by pharmacists and care coordination teams before the specialty drug is given to the patient. Obviously, there’s a higher cost, and so it takes more personnel and systems, so there is more patient coordination needed prior to the pharmacy to dispense that specialty medication. The value of the specialty pharmacist in helping patients to access treatment, adhere to treatment, and really get the best possible outcome of treatment really cannot be overstressed as specialty pharmacist are often responsible for selecting the most appropriate therapy based on the patient's clinical and financial profile or reviewing that prescribed medication to ensure access for the patient. The Specialty Pharmacy Care Teams provide significant mentoring to patients to ensure not only safety but also effectiveness and being proactive and changing therapy so that patients are really getting the best possible benefit or changing to a different medication that may give them a better effect. The specialty pharmacists are an anchor during therapy that they can rely on to make sure that they are helping them deal with complex, challenging, and sometimes lifelong therapies as the specialty care teams play an important role in the patient care journey. Learn more about your ad choices. Visit megaphone.fm/adchoices

·      Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer ·      Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy Faculty: Sarah Hayward, PharmD, BCOP Clinical Pharmacy Specialist, Gynecologic Oncology Stephenson Cancer Center at OU Health University of Oklahoma Health Science Center Oklahoma City, Oklahoma Sarah Hayward, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Consultant (advisory board): GSK, Seagen/Genmab Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-322-H01-P. The activity is available for CE credit through June 30, 2023. This educational activity is supported by an educational grant from GlaxoSmithKline Learn more about your ad choices. Visit megaphone.fm/adchoices

The use of oral therapies for chronic lymphocytic leukemia has had a great impact on patient outcomes and quality of life. Pharmacists can play a key role in assisting with therapy selection, education for patients and the healthcare team, and also managing adverse effects for patients receiving these therapies. Objectives Differentiate novel therapies for the treatment of chronic lymphocytic leukemia (CLL) by pharmacologic properties and special considerations for use Associate drug therapy and safety and efficacy information with treatment selection for patients with CLL Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida. Dr. Tobon has no relevant financial relationships with commercial interests to disclose. Accreditation and support statement:  PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd. Learn more about your ad choices. Visit megaphone.fm/adchoices

This podcast will specifically focus on clinical safety and efficacy data supporting the use of new and emerging JAK inhibitors in the management of AD. Practical counseling points for pharmacists to provide individualized care and proper selection of therapy to patients with AD who are initiating therapy with JAK inhibitors will also be discussed. Faculty experts will review audience questions and identify best practices in the management of AD. o  The Role of JAK Inhibitors in the Management of Atopic Dermatitis: Latest Advances and Best Practices for the Pharmacist o  Introduction of faculty, affiliations, and disclosures We would like to thank Sarah Lant, PharmD for her contribution in developing the content for this podcast. Lana Gerzenshtein, PharmD and Sarah Lant have no relevant financial relationships with commercial interests to disclose. o  Accreditation and support statement PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. This activity is supported by educational grants from Incyte. Learn more about your ad choices. Visit megaphone.fm/adchoices

Introduction of faculty and disclosures:  Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida. Dr. Tobon has no relevant financial relationships with commercial interests to disclose. Accreditation and support statement:  PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd. Learn more about your ad choices. Visit megaphone.fm/adchoices

Join us today as we talk all things continuous glucose monitoring with a diabetes care and education specialist, Dr. Diana Isaacs. Learn more about the barriers and challenges associated with using CGM for your patients and strategies to overcome these challenges. In addition, Dr. Diana Isaacs walks us through the newest technologies and innovations in the diabetes management space as diabetes care has transformed drastically in the last decade.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Today I want to highlight the work of another pharmacy and entrepreneur colleague, Dr. Stephanie Young Moss (aka “Yomo”). She caught my eye on Instagram, where she shines her light on wellness, family dynamics, pharmacy practice, and disparities in healthcare. A practical tip that she shared in the episode has stuck with me, about how learning goes both ways. For example, shadowing allows healthcare students to learn from professionals, but the mentors also get the opportunity to learn. A relationship with someone different than you helps you understand where they’re coming from and how you can serve different populations. Dr. Stephanie received her Doctor of Pharmacy degree from Xavier University of Louisiana College of Pharmacy and a Masters of Health Services Administration with a concentration in Health Economics from The University of Wyoming. She has worked in various areas in pharmacy, Community, Regulatory Compliance, Managed Care, and Health Economics and Outcomes Research. Over the past 20 years Dr. Moss has advocated for decreasing disparities in health care through her volunteer work. She uses her platform to educate families across the U.S. on ways to decrease and eliminate health disparities by incorporating simple wellness and mental health techniques. Dr. Moss has shared her views on international and national podcasts and local television news stations. Dr. Stephanie is the creator of the website www.drstephanieyomo.com where you will find practical health and wellness tips, ways to reduce healthcare disparities and simple tips for health and wellness professionals to enhance their presence on social media so they can stand out in their niche, build a successful brand and advocate for important causes. She is also the owner of Integrative Pharmacy Outcomes and Consulting, which focuses on educating underserved communities on ways to reduce and prevent health disparities. For nearly 2 decades, Dr. Stephanie has served on various boards and volunteer organizations that focus on health equity, decreasing implicit bias, addressing social determinants of health and empowering communities to advocate for their health. She has served on the boards for The Minority Health Coalition of Marion County and Eskenazi Health Center where she has served as the Clinical Quality Committee Chair, Board Secretary and is currently the Board Treasurer. She resides in Indianapolis, Indiana. You can connect with Dr. Yomo on all social media (@Dr. Stephanie Yomo) and www.drstephanieyomo.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Please join the discussion with David George from Total Dose Pharmacy and First Financial Loan Officer, Drew Hegi from First Financial Bank.  David George is one of the founders of Total Dose Pharmacy that was established in 2013. He began the startup in Oklahoma and subsequently a second store, Hutton Pharmacy.  Total Dose aims to be embedded as a healthcare cornerstone of every community in which they are located. They strive to be innovative in the services and products they offer, as well as experts in provision of care and education to patients. Ultimately, their goal is to be the pharmacy franchise where patients want to receive healthcare and people want to work. Drew Hegi, has been a Loan Officer at FFB since 2012. Drew is also an Independent Pharmacy owner. Drew enjoys coaching buyers through the details of pharmacy ownership. Clear communication helps alleviate concerns, and he understands the necessary skills and tools needed to navigate the process. Learn more about your ad choices. Visit megaphone.fm/adchoices

https://www.rx-summit.com/ Dr. Mark Garofoli was live and in person at the 2022 RxSummit Conference which hosted anyone and everyone affiliated with and touched by our country's Drug Crisis. The "Pain Guy" spoke with many federal and state leaders (including our U.S. Drug Czar Dr. Gupta, our NIDA Director Dr. Volkow, DEA leadership, and so on), along with fellow conference presenters and attendees alike. Many of those conversations were recorded and contained within this dynamic conference summary episode of the Pain Pod! Learn more about your ad choices. Visit megaphone.fm/adchoices